Skip to content

ANTIPODES PARTNERS Ltd: B position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on B, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 3,837,977 B shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 3,837,977 shares
    Change vs previous 13F -217,558 shares

    2.58% of the 13F portfolio, value $140,972,197.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 4,055,535 shares
    Change vs previous 13F -420,190 shares

    3.19% of the 13F portfolio, value $165,418,890.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 4,475,725 shares
    Change vs previous 13F -1,151,445 shares

    4.09% of the 13F portfolio, value $194,936,957.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 5,627,170 shares
    Change vs previous 13F -2,503,924 shares

    4.14% of the 13F portfolio, value $184,416,273.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 8,131,094 shares
    Change vs previous 13F not available

    5.25% of the 13F portfolio, value $169,302,293.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).